Cargando…

Age of heart disease presentation and dysmorphic nuclei in patients with LMNA mutations

Nuclear shape defects are a distinguishing characteristic in laminopathies, cancers, and other pathologies. Correlating these defects to the symptoms, mechanisms, and progression of disease requires unbiased, quantitative, and high-throughput means of quantifying nuclear morphology. To accomplish th...

Descripción completa

Detalles Bibliográficos
Autores principales: Core, Jason Q., Mehrabi, Mehrsa, Robinson, Zachery R., Ochs, Alexander R., McCarthy, Linda A., Zaragoza, Michael V., Grosberg, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693421/
https://www.ncbi.nlm.nih.gov/pubmed/29149195
http://dx.doi.org/10.1371/journal.pone.0188256
_version_ 1783279935488524288
author Core, Jason Q.
Mehrabi, Mehrsa
Robinson, Zachery R.
Ochs, Alexander R.
McCarthy, Linda A.
Zaragoza, Michael V.
Grosberg, Anna
author_facet Core, Jason Q.
Mehrabi, Mehrsa
Robinson, Zachery R.
Ochs, Alexander R.
McCarthy, Linda A.
Zaragoza, Michael V.
Grosberg, Anna
author_sort Core, Jason Q.
collection PubMed
description Nuclear shape defects are a distinguishing characteristic in laminopathies, cancers, and other pathologies. Correlating these defects to the symptoms, mechanisms, and progression of disease requires unbiased, quantitative, and high-throughput means of quantifying nuclear morphology. To accomplish this, we developed a method of automatically segmenting fluorescently stained nuclei in 2D microscopy images and then classifying them as normal or dysmorphic based on three geometric features of the nucleus using a package of Matlab codes. As a test case, cultured skin-fibroblast nuclei of individuals possessing LMNA splice-site mutation (c.357-2A>G), LMNA nonsense mutation (c.736 C>T, pQ246X) in exon 4, LMNA missense mutation (c.1003C>T, pR335W) in exon 6, Hutchinson-Gilford Progeria Syndrome, and no LMNA mutations were analyzed. For each cell type, the percentage of dysmorphic nuclei, and other morphological features such as average nuclear area and average eccentricity were obtained. Compared to blind observers, our procedure implemented in Matlab codes possessed similar accuracy to manual counting of dysmorphic nuclei while being significantly more consistent. The automatic quantification of nuclear defects revealed a correlation between in vitro results and age of patients for initial symptom onset. Our results demonstrate the method’s utility in experimental studies of diseases affecting nuclear shape through automated, unbiased, and accurate identification of dysmorphic nuclei.
format Online
Article
Text
id pubmed-5693421
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-56934212017-11-30 Age of heart disease presentation and dysmorphic nuclei in patients with LMNA mutations Core, Jason Q. Mehrabi, Mehrsa Robinson, Zachery R. Ochs, Alexander R. McCarthy, Linda A. Zaragoza, Michael V. Grosberg, Anna PLoS One Research Article Nuclear shape defects are a distinguishing characteristic in laminopathies, cancers, and other pathologies. Correlating these defects to the symptoms, mechanisms, and progression of disease requires unbiased, quantitative, and high-throughput means of quantifying nuclear morphology. To accomplish this, we developed a method of automatically segmenting fluorescently stained nuclei in 2D microscopy images and then classifying them as normal or dysmorphic based on three geometric features of the nucleus using a package of Matlab codes. As a test case, cultured skin-fibroblast nuclei of individuals possessing LMNA splice-site mutation (c.357-2A>G), LMNA nonsense mutation (c.736 C>T, pQ246X) in exon 4, LMNA missense mutation (c.1003C>T, pR335W) in exon 6, Hutchinson-Gilford Progeria Syndrome, and no LMNA mutations were analyzed. For each cell type, the percentage of dysmorphic nuclei, and other morphological features such as average nuclear area and average eccentricity were obtained. Compared to blind observers, our procedure implemented in Matlab codes possessed similar accuracy to manual counting of dysmorphic nuclei while being significantly more consistent. The automatic quantification of nuclear defects revealed a correlation between in vitro results and age of patients for initial symptom onset. Our results demonstrate the method’s utility in experimental studies of diseases affecting nuclear shape through automated, unbiased, and accurate identification of dysmorphic nuclei. Public Library of Science 2017-11-17 /pmc/articles/PMC5693421/ /pubmed/29149195 http://dx.doi.org/10.1371/journal.pone.0188256 Text en © 2017 Core et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Core, Jason Q.
Mehrabi, Mehrsa
Robinson, Zachery R.
Ochs, Alexander R.
McCarthy, Linda A.
Zaragoza, Michael V.
Grosberg, Anna
Age of heart disease presentation and dysmorphic nuclei in patients with LMNA mutations
title Age of heart disease presentation and dysmorphic nuclei in patients with LMNA mutations
title_full Age of heart disease presentation and dysmorphic nuclei in patients with LMNA mutations
title_fullStr Age of heart disease presentation and dysmorphic nuclei in patients with LMNA mutations
title_full_unstemmed Age of heart disease presentation and dysmorphic nuclei in patients with LMNA mutations
title_short Age of heart disease presentation and dysmorphic nuclei in patients with LMNA mutations
title_sort age of heart disease presentation and dysmorphic nuclei in patients with lmna mutations
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693421/
https://www.ncbi.nlm.nih.gov/pubmed/29149195
http://dx.doi.org/10.1371/journal.pone.0188256
work_keys_str_mv AT corejasonq ageofheartdiseasepresentationanddysmorphicnucleiinpatientswithlmnamutations
AT mehrabimehrsa ageofheartdiseasepresentationanddysmorphicnucleiinpatientswithlmnamutations
AT robinsonzacheryr ageofheartdiseasepresentationanddysmorphicnucleiinpatientswithlmnamutations
AT ochsalexanderr ageofheartdiseasepresentationanddysmorphicnucleiinpatientswithlmnamutations
AT mccarthylindaa ageofheartdiseasepresentationanddysmorphicnucleiinpatientswithlmnamutations
AT zaragozamichaelv ageofheartdiseasepresentationanddysmorphicnucleiinpatientswithlmnamutations
AT grosberganna ageofheartdiseasepresentationanddysmorphicnucleiinpatientswithlmnamutations